Back to search
FDAFDA · Food and drugs·Recall number D-1097-2020

Hydroxyprogesterone Caproate (BUD) 350mg/ml , 4 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA 92562 951-304-9530

Published April 15, 2020 · Recall initiated: March 26, 2020

Summary

FDA records drug Class II recall D-1097-2020, published April 15, 2020 and initiated March 26, 2020. Recalling firm: Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy; Status: Terminated; Reported quantity: N/A; Lot: Lot #: 02212020@2, Expires after 04-21-2020; Lot #: 02262020@52 Expires after 04-26-2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
Distributor
Patient Distribution list includes addresses in the following states: CA, ME, TX
Lot
Lot #: 02212020@2, Expires after 04-21-2020; Lot #: 02262020@52 Expires after 04-26-2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydroxyprogesterone Caproate (BUD) 350mg/ml , 4 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA 92562 951-304-9530 recalled?

Yes. FDA published recall D-1097-2020 on April 15, 2020. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter